SCHEMBL14126554

SCHEMBL14126554

O=CC1(O)COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21581979 0.71
SCHEMBL19757233 0.69
SCHEMBL1683908 0.69
SCHEMBL16322901 0.69
SCHEMBL934983 0.65
SCHEMBL4041737 0.65
SCHEMBL14126181 0.63
SCHEMBL2777248 0.62 ALDH1A1 (0.33)
SCHEMBL569237 0.62
SCHEMBL14126414 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025067111-A1 MENIN-MLL INTERACTION INHIBITOR AND PREPARATION METHOD THEREFOR, AND APPLICATION 苏州必扬医药科技有限公司 2025-04-03 WO disclosed
CN-115894497-A Imidazopyrimidine compounds, and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-04-04 CN disclosed
CN-113727758-A Bicyclic heterocyclic compounds and use thereof 锐新医药公司 2021-11-30 CN disclosed
EP-3789378-A1 PIPERIDINES OR PIPERIDONES SUBSTITUTED WITH UREA AND HETEROARYL Grünenthal GmbH (DE) 2021-03-10 EP disclosed
US-20190031676-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-01-31 US disclosed
EP-3341378-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES Idorsia Pharmaceuticals Ltd (CH) 2018-07-04 EP disclosed
WO-2017036968-A1 ANTIBACTERIAL ANNULATED PYRROLIDIN-2-ONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2017-03-09 WO disclosed
WO-2012163456-A1 NOVEL P2X7R ANTAGONISTS AND THEIR USE AFFECTIS PHARMACEUTICALS AG (DE) 2012-12-06 WO disclosed
WO-2012163792-A1 NOVEL P2X7R ANTAGONISTS AND THEIR USE AFFECTIS PHARMACEUTICALS AG (DE) 2012-12-06 WO disclosed